XML 202 R48.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Cost and Associated Tax Benefit
Presented below is a summary of the stock-based compensation expense and associated tax benefit in the accompanying consolidated statements of operations:
Year Ended December 31,
202420232022
Stock-based compensation expense$221 $193 $169 
Tax benefit$48 $45 $41 
Weighted Average Assumptions used in Determining Fair Value for Options Granted
The following weighted average assumptions were used for options granted:
Year Ended December 31,
202420232022
Expected dividend yield0.91 %1.04 %0.86 %
Expected stock volatility28 %29 %27 %
Risk-free interest rate4.34 %4.19 %1.91 %
Expected holding period (in years)5.95.85.6
Grant date fair value
$120.42 $94.71 $84.00 
Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity
A summary of option activity as of December 31, 2024 and changes during the year then ended is presented below:
OptionsSharesWeighted Average Exercise Price Per ShareWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding, December 31, 2023
0.8 $212.29 
Granted0.2 $372.52 
Exercised(0.3)$173.64 
Outstanding, December 31, 2024
0.7 $267.64 5.9 years$140 
Vested and expected to vest, December 31, 2024
0.7 $267.26 5.9 years$139 
Exercisable, December 31, 2024
0.4 $207.94 4.0 years$99 
Stock Option Exercises and Restricted Stock Vesting
The following table summarizes information relating to stock option exercises:
Year Ended December 31,
202420232022
Proceeds from stock option exercises$53 $32 $
Aggregate intrinsic value$76 $58 $
Tax benefit realized upon exercise$13 $14 $
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
A summary of nonvested restricted stock activity for the year ended December 31, 2024 is presented below:
Nonvested Restricted StockSharesWeighted Average Grant Date Fair Value Per Share
Balance, December 31, 2023
1.3 $300.39 
Granted0.6 $373.54 
Vested(0.5)$300.20 
Forfeited(0.1)$327.53 
Balance, December 31, 2024
1.3 $330.84 
A summary of performance-based restricted stock activity for the year ended December 31, 2024 is presented below:
Performance-based restricted stockSharesWeighted Average Grant Date Fair Value Per Share
Balance, December 31, 2023
0.3 $308.12 
Granted0.1 $354.67 
Vested(0.1)$331.60 
Balance, December 31, 2024
0.3 $330.78 
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest
The following table summarizes information relating to the vesting of restricted stock awards:
Year Ended December 31,
202420232022
Fair value of shares vested$199 $164 $180 
Tax benefit realized upon vesting$48 $40 $42 
The following table summarizes information relating to the vesting of the Company’s performance-based restricted stock awards:
Year Ended December 31,
202420232022
Fair value of shares vested$40 $24 $50 
Tax benefit realized upon vesting$9 $$